Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration

Journal of Pharmacology and Experimental Therapeutics

Volumn 242, Issue 2, 1987, Pages 428-436

  Gmerek, D E ^a   Dykstra, L A ^a   Woods, J H ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 5,9 DIETHYL 2 (3 FURYLMETHYL) 2' HYDROXY 6,7 BENZOMORPHAN; BETA FUNALTREXAMINE; BREMAZOCINE; BUPRENORPHINE; CYCLAZOCINE; KAPPA OPIATE RECEPTOR; MORPHINE; N (TETRAHYDROFURFURYL)NORMETAZOCINE; NALORPHINE; NALOXONE; NALTREXONE; QUADAZOCINE;

ANIMAL EXPERIMENT; BEHAVIOR; CENTRAL NERVOUS SYSTEM; CROSS TOLERANCE; DOSE RESPONSE; DRUG DEPENDENCE; DRUG RESPONSE; DRUG TOLERANCE; MONKEY; NONHUMAN; PHARMACOKINETICS; PSYCHOLOGICAL ASPECT; SUBCUTANEOUS DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE , (TRANS)-ISOMER; ANIMAL; BENZODIAZEPINES; BENZOMORPHANS; CYCLAZOCINE; DRUG TOLERANCE; ENDORPHINS; ETHYLKETOCYCLAZOCINE; MACACA MULATTA; MORPHINANS; MORPHINE; NARCOTIC ANTAGONISTS; PENTOBARBITAL; PYRROLIDINES; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0023637787     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)